IT8348593A0 - Frazione antigenica seminale purificata, procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti - Google Patents

Frazione antigenica seminale purificata, procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti

Info

Publication number
IT8348593A0
IT8348593A0 IT8348593A IT4859383A IT8348593A0 IT 8348593 A0 IT8348593 A0 IT 8348593A0 IT 8348593 A IT8348593 A IT 8348593A IT 4859383 A IT4859383 A IT 4859383A IT 8348593 A0 IT8348593 A0 IT 8348593A0
Authority
IT
Italy
Prior art keywords
spermiagglutinant
antibodies
dosage
procedure
preparation
Prior art date
Application number
IT8348593A
Other languages
English (en)
Other versions
IT1197670B (it
Inventor
Sartori Claudia
Original Assignee
Serono Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Ist Farm filed Critical Serono Ist Farm
Priority to IT48593/83A priority Critical patent/IT1197670B/it
Publication of IT8348593A0 publication Critical patent/IT8348593A0/it
Priority to EP84830195A priority patent/EP0131552A3/en
Priority to DE198484830195T priority patent/DE131552T1/de
Priority to JP59132123A priority patent/JPS6045519A/ja
Application granted granted Critical
Publication of IT1197670B publication Critical patent/IT1197670B/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT48593/83A 1983-06-29 1983-06-29 Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti IT1197670B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT48593/83A IT1197670B (it) 1983-06-29 1983-06-29 Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti
EP84830195A EP0131552A3 (en) 1983-06-29 1984-06-27 Purified seminal antigenic fraction, process for its preparation and use of said fraction for the dosage of the spermagglutinating antibodies
DE198484830195T DE131552T1 (de) 1983-06-29 1984-06-27 Gereinigte spermantigenfraktion, verfahren zu ihrer herstellung und verwendung dieser fraktion zur dosierung spermagglutinierender antikoerper.
JP59132123A JPS6045519A (ja) 1983-06-29 1984-06-28 精液抗原画分及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48593/83A IT1197670B (it) 1983-06-29 1983-06-29 Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti

Publications (2)

Publication Number Publication Date
IT8348593A0 true IT8348593A0 (it) 1983-06-29
IT1197670B IT1197670B (it) 1988-12-06

Family

ID=11267518

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48593/83A IT1197670B (it) 1983-06-29 1983-06-29 Frazione antigenica seminale purificata,procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti

Country Status (4)

Country Link
EP (1) EP0131552A3 (it)
JP (1) JPS6045519A (it)
DE (1) DE131552T1 (it)
IT (1) IT1197670B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741998A (en) * 1985-06-05 1988-05-03 The University Of Virginia Alumni Patents Foundation Monoclonal antibody to MHS-5: a new probe for sexual assault analyses
JPS61294366A (ja) * 1985-06-24 1986-12-25 Toubishi Yakuhin Kogyo Kk 糖鎖に特異的な抗体の検出用試薬及びその使用
JP2534480B2 (ja) * 1986-10-16 1996-09-18 晋三 礒島 ヒト精子不動化抗体の対応抗原
JPH0323473U (it) * 1989-07-12 1991-03-12
EP0410816B1 (en) * 1989-07-28 1998-01-14 Wisconsin Alumni Research Foundation Detection of heparin binding seminal proteins

Also Published As

Publication number Publication date
EP0131552A3 (en) 1987-08-12
IT1197670B (it) 1988-12-06
JPS6045519A (ja) 1985-03-12
EP0131552A2 (en) 1985-01-16
JPS6339573B2 (it) 1988-08-05
DE131552T1 (de) 1985-05-09

Similar Documents

Publication Publication Date Title
IT1160468B (it) Procedimento per la produzione di anticorpi monoclonali umani
FI925631L (fi) Monoklonala antikroppar
IT1161803B (it) Tessuto biologico e procedimento per la sua preparazione
DK398887D0 (da) Antistoffer
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
NO864971L (no) Fremgangsmaate for fremstilling av monoklonale antistoffer som er kryssbeskyttende overfor p. aeruginosaserotyper.
FI862761A0 (fi) Klonad antigen.
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
DK109887D0 (da) Farmaceutisk praeparat indeholdende antistoffer
IT8468197A0 (it) Procedimento per la formazione di cataste di oggetti tubolari e simili e dispositivo per la sua attuazione
IT7968342A0 (it) Sostanza anti tumorale e procedimento per la sua preparazione
IT8348593A0 (it) Frazione antigenica seminale purificata, procedimento per la sua preparazione ed impiego della stessta per il dosaggio degli anticorpi spermioagglutinanti
TR24991A (tr) Yeni yumusatma bilesimleri ve bunlarin hazirlanma- si ve kullanilmasi icin yöntemler
TR23163A (tr) Oksit borigin hazirlanmasina mahsus gelistirilmis usul
GB8804802D0 (en) Preparation of monoclonal antibodies
EP0205046A3 (en) Monoclonal antibody to human protein c
IT1140318B (it) Enzima terapeuticamento utile e procedimento per la sua preparazione
IT1165580B (it) N.s-diacetilcisteina e procedimento per la sua preparazione
DK240286D0 (da) Monoklonale antistoffer
DK554986D0 (da) Antistof
IT1148890B (it) Derivato della teonil tiopropionil glicina e procedimento per la sua preparazione
DK554886A (da) Antistoffer
IT1168076B (it) Procedimento per la preparazione della pantetina
IT1149884B (it) Prozedimento per la preparazione della n-(2-tenoil)tiopropionil)-glicina
NO173340C (no) Humant protein C antistoff

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940622